Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression

Clin Lung Cancer. 2023 May;24(3):e117-e121. doi: 10.1016/j.cllc.2023.01.003. Epub 2023 Jan 25.
No abstract available

Keywords: Biomarkers; Liquid biopsy; Lung cancer; Precision medicine; Targeted therapy.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma of Lung* / genetics
  • Biomarkers, Tumor
  • Biopsy
  • Disease Progression
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Mutation

Substances

  • Biomarkers, Tumor